Keys To Success: Maniacal Focus And Adaptive Readiness

With an engineer’s mind, Jason Park, CEO of Empress Therapeutics, has a unique take on problem solving for fundraising and the value of being a platform company focused on small molecules.

formula
Jason Park Says Small Molecules Have A Host Of Advantages Over More Advanced Therapies • Source: Shutterstock

Rising Leaders Home

Jason Park’s entry into the biotech world came about serendipitously. As a biomedical engineering student at Yale University, Park spent...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Rising Leaders

More from Leadership